Pilot--Assembly and Regulation of Dynein: Role of the Intermediate Chains

试点——动力蛋白的组装和调控:中间链的作用

基本信息

  • 批准号:
    7459935
  • 负责人:
  • 金额:
    $ 5.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

The overall goal of my research is to determine the mechanism and regulation of dynein with particular emphasis on flagellar dyneins. Dynein is ubiquitous and essential family of microtubule motors that is involved in many vital biological processes such as left-right patterning during development, chromosome segregation, vesicular trafficking, and ciliary and flagellar motility. One of the major questions about dyneins that remains unanswered is: What is the mechanism of dynein isoform targeting and anchoring to cargo? This proposal focuses on the role of dynein intermediate chains in targeting dynein to cargo, taking advantage of the flagella inner arm dynein I1 in Chlamydomonas. The I1 dynein is targeted and anchored to a unique position on the A-microtubule. Additionally, chemical cross-linking studies revealed that the inner arm dynein I1 intermediate chains IC138 and IC140 each independently interact with a third 90 kDa protein. I postulate that the 90 kDa protein is either the third intermediate chain in I1 IC97,or more likely, a novel protein that mediated the docking of the I1 dynein complex to the microtubule. To test these ideas three aims are proposed: (1) Identify the 90 kDa protein. A novel enrichment procedure will be used to purify the cross-linked product and tandem mass spectrometry will be performed to identify the protein. Possible outcomes include the interacting protein is a previously unidentified protein, or the interacting protein is the third intermediate chain dynein in I1, IC97. (2) If the 90 kDa protein is a novel protein the gene will be cloned, mapped and antibodies generated. (3) If the mass spectrometry data reveal that the 90 kDa protein is IC97 then it will be important to map the interaction sites on IC138 and IC140. However, if the 90 kDa protein is a novel protein then the hypothesis that it is part of the docking mechanism for I1 will be tested. These data will define protein interactions within the axonemal inner arm dynein complex I1. The data will also reveal new principles for docking of dynein, leading to a better understanding of human diseases that result from defects in dynein assembly and regulation, such as primary cilia dyskinesia, defective left-right patterning during development, male infertility, and impaired female fertility.
我的研究的总体目标是确定动力蛋白的机制和调节, 强调鞭毛动力蛋白。动力蛋白是微管马达中普遍存在的重要家族, 参与许多重要的生物过程,如发育过程中的左右模式,染色体 分离,囊泡运输,纤毛和鞭毛运动。动力蛋白的一个主要问题是 动力蛋白异构体靶向和锚定货物的机制是什么? 这项建议的重点是动力蛋白中间链的作用,针对动力蛋白的货物, 鞭毛内臂动力蛋白I1的优势。I1动力蛋白靶向并锚定于 A微管上的一个独特位置此外,化学交联研究表明, 臂动力蛋白I1中间链IC 138和IC 140各自独立地与第三个90 kDa蛋白相互作用。我假设,90 kDa的蛋白质是I1 IC97中的第三个中间链,或者更有可能是介导I1动力蛋白复合物与微管对接的一种新蛋白质。为了验证这些想法,提出了三个目标:(1)鉴定90 kDa蛋白。将使用一种新的富集程序来纯化交联产物,并进行串联质谱法来鉴定蛋白质。可能的结果包括相互作用蛋白质是以前未鉴定的蛋白质,或者相互作用蛋白质是I1中的第三中间链动力蛋白,IC 97。(2)如果90 kDa蛋白质是一种新的蛋白质,则将克隆该基因,绘制图谱并产生抗体。(3)如果质谱数据显示 如果90 kDa蛋白质是IC97,那么在IC138和IC140上定位相互作用位点将是重要的。 然而,如果90 kDa蛋白是一种新蛋白,那么它是对接机制的一部分的假设 将测试I1。这些数据将确定蛋白质相互作用的轴丝内臂动力蛋白 复合物I1。这些数据还将揭示动力蛋白对接的新原理,从而更好地理解 由于动力蛋白组装和调节的缺陷而导致的人类疾病,如初级纤毛 运动障碍、发育过程中的左右模式缺陷、男性不育和女性生育能力受损。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TRISCIA W HENDRICKSON其他文献

TRISCIA W HENDRICKSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TRISCIA W HENDRICKSON', 18)}}的其他基金

Pilot--Assembly and Regulation of Dynein: Role of the Intermediate Chains
试点——动力蛋白的组装和调控:中间链的作用
  • 批准号:
    7141418
  • 财政年份:
    2006
  • 资助金额:
    $ 5.87万
  • 项目类别:
Pilot--Assembly and Regulation of Dynein: Role of the Intermediate Chains
试点——动力蛋白的组装和调控:中间链的作用
  • 批准号:
    7893750
  • 财政年份:
  • 资助金额:
    $ 5.87万
  • 项目类别:
Pilot--Assembly and Regulation of Dynein: Role of the Intermediate Chains
试点——动力蛋白的组装和调控:中间链的作用
  • 批准号:
    7645807
  • 财政年份:
  • 资助金额:
    $ 5.87万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 5.87万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 5.87万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 5.87万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 5.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了